Open Access

P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling

  • Authors:
    • Qiang Zhang
    • Yue Yin
    • Hongye Zhao
    • Yan Shi
    • Wei Zhang
    • Zhengpeng Yang
    • Tingting Liu
    • Yonghong Huang
    • Zhanjiang Yu
  • View Affiliations

  • Published online on: December 23, 2020     https://doi.org/10.3892/ol.2020.12406
  • Article Number: 145
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colorectal cancer (CRC) is the third most commonly diagnosed malignancy that is associated with high levels of mortality. CRCs are often associated with an aberrant wingless‑type mouse mammary tumor virus integration site family (Wnt) signaling pathway known to be responsible for tumorigenesis and cancer progression. Other factors that contribute to CRC pathology include hypoxia, extracellular matrix and cellular microenvironment. In the present study, modulation of Wnt, a common molecular progenitor for CRC‑associated pathology was evaluated. CRC tissues and specific cell lines were found to exhibit increased expression levels of prolyl 4‑hydroxylase subunit α1 (P4HA1). P4HA1 expression was found to stabilize hypoxia inducible factor‑1α (HIF1α). The silencing of P4HA1 resulted in decreased cell proliferation, cell cycle arrest in the G1 phase, decreased tumorsphere formation, decreased tumorsphere volume, increased susceptibility to 5‑fluorouracil and increased caspase‑3 activity. However, P4HA1 silencing resulted in the activation and thus proteasomal degradation of β‑catenin, indicative of the abrogation of Wnt signaling pathway. Wnt is a critical signaling pathway and is activated in most CRCs. HIF1α is a poor prognostic marker in CRC. The present study provided preliminary evidence that HIF1α and the Wnt signaling pathway in CRC are modulated through P4HA1. P4HA1 may serve not just as a biomarker for CRC prognosis but may also be targeted for potential therapeutic intervention.
View Figures
View References

Related Articles

Journal Cover

February-2021
Volume 21 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Yin Y, Zhao H, Shi Y, Zhang W, Yang Z, Liu T, Huang Y and Yu Z: P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling. Oncol Lett 21: 145, 2021
APA
Zhang, Q., Yin, Y., Zhao, H., Shi, Y., Zhang, W., Yang, Z. ... Yu, Z. (2021). P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling. Oncology Letters, 21, 145. https://doi.org/10.3892/ol.2020.12406
MLA
Zhang, Q., Yin, Y., Zhao, H., Shi, Y., Zhang, W., Yang, Z., Liu, T., Huang, Y., Yu, Z."P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling". Oncology Letters 21.2 (2021): 145.
Chicago
Zhang, Q., Yin, Y., Zhao, H., Shi, Y., Zhang, W., Yang, Z., Liu, T., Huang, Y., Yu, Z."P4HA1 regulates human colorectal cancer cells through HIF1α‑mediated Wnt signaling". Oncology Letters 21, no. 2 (2021): 145. https://doi.org/10.3892/ol.2020.12406